Endothelin-1 polymorphism involved in the impaired exercise tolerance in COPD patients: A precursor of pulmonary hypertension?

D. Lykouras, F. Sampsonas, A. Kaparianos, K. Karkoulias, K. Spiropoulos (Greece)

Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Session: Gas exchange and paediatric exercise testing
Session type: Thematic Poster Session
Number: 892
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Lykouras, F. Sampsonas, A. Kaparianos, K. Karkoulias, K. Spiropoulos (Greece). Endothelin-1 polymorphism involved in the impaired exercise tolerance in COPD patients: A precursor of pulmonary hypertension?. Eur Respir J 2010; 36: Suppl. 54, 892

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension reduces exercise tolerance in COPD
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010

Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010


Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

Serum levels of RAAS components in COPD
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


Pulmonary hypertension and endothelial dysfunction in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007

Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005


Prevalence of established and exercise induced pulmonary hypertension in COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011

microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015

Endothelial dysfunction at the patients with COPD with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 415s
Year: 2001

Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008


The link between systemic inflammation and pulmonary hypertension in patients with stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005

Contrasting exercise cerebral oxigenation in COPD patients with and without chronic heart failure
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013


Reduced exercise capacity and impaired pulmonary function in patients with scleroderma
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010

Pulmonary rehabilitation modulates neurohumoral activation in patients with COPD
Source: Annual Congress 2006 - Physiological responses to rehabilitation
Year: 2006


Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Impaired glucose tolerance in COPD patients with hypoxaemia
Source: Eur Respir J 2001; 18: Suppl. 33, 211s
Year: 2001

Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension.
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation
Source: Eur Respir J 2014; 43: 1306-1315
Year: 2014



Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016